What cold medicine was recently taken off the market?: The FDA Ruling on Oral Phenylephrine
•
4 min read
In September 2023, a U.S. Food and Drug Administration (FDA) advisory committee unanimously concluded that oral phenylephrine is ineffective as a nasal decongestant, leading to the removal of countless popular over-the-counter cold medications from store shelves. This decision impacts a significant portion of the cold and flu market, with oral decongestants featuring phenylephrine accounting for roughly $1.8 billion in annual sales.
